Abstract
BackgroundHypertonia is a primary motor impairment in children-and-young-people with cerebral palsy (CYPwCP) and significantly contributes to secondary musculoskeletal impairment impacting on activity and participation. Botulinum Toxin-A (BoNT-A) is used for...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Archives of disease in childhood. Fetal and neonatal edition
Paper Title
Journal
Date
